Acquired Lipodystrophy can occur due to various triggers and presents with a range of symptoms depending on the type. Here's a breakdown of the Acquired Lipodystrophy causes and symptoms:Causes of ...

The U.S. Food and Drug Administration has approved Myalept, metreleptin for injection, as a treatment option for patients with congenital generalized or acquired generalized lipodystrophy.

Many people may have a dim view of their fat tissue, yet scientists have come to recognize adipose as a necessary and metabolically active organ, carrying out many vital functions within the body. In ...

NEW YORK, 26 July (Praxis Press) The human immunodeficiency virus (HIV) lipodystrophy syndrome is characterized by fat redistribution and insulin resistance; this syndrome is particularly common among ...

Bristol-Myers Squibb Company BMY and AstraZeneca AZN today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted a Priority Review designation for the Biologics License ...

SAN DIEGO--(BUSINESS WIRE)--Entos ® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures and improve the lives of ...

Entos Pharmaceuticals Inc. has been awarded a $4 million grant by California Institute for Regenerative Medicine (CIRM) to support the completion of IND-enabling activities with ENTLEP-001, a durable ...